{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:06:03Z","timestamp":1789257963667,"version":"build-2803163510"},"reference-count":23,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Aerosol Medicine and Pulmonary Drug Delivery"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Intranasal corticosteroids (INCSs) are widely prescribed for allergic and nonallergic rhinitis and chronic rhinosinusitis, frequent causes of upper airway cough syndrome (UACS). In UACS, adherence is strongly influenced not only on pharmacological efficacy but also on device performance and sensory tolerability. Despite this, few studies have linked\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      spray characteristics with patient-reported outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>\n                      To evaluate the technological characteristics and clinical acceptability of mometasone furoate administered via the liquid VP3 nasal spray device by integrating\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      performance testing and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      patient-reported outcomes in individuals with chronic cough and UACS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">In vitro<\/jats:italic>\n                      experiments assessed deposition patterns in a silicone nasal cast, dripping behavior on inclined gel surfaces, viscosity, and spray plume geometry. An observational study enrolled 10 patients (80% female, mean age 56 \u00b1 8.4 years) referred to a tertiary cough clinic for chronic cough (mean duration 3.5 years) associated with postnasal drip. Patients switched from conventional mometasone sprays to the device and completed Anchored Best\u2013Worst Scaling evaluations of 11 sensory and treatment-related attributes. Global satisfaction was rated using a visual analog scale (VAS) and Treatment Satisfaction Index (TSI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Deposition was reproducible (27.9 \u00b1 1.7% of cast surface) with distribution into middle and lower turbinates. Moderate viscosity (14.4\u2009\u00b1\u20093.2 mPa\u00b7s) and stable plume geometry supported retention.\n                      <jats:italic toggle=\"yes\">In vivo<\/jats:italic>\n                      , overall satisfaction scores remained stable following switching (TSI: 64.3\u2009\u00b1\u20093.4 vs 63.8\u2009\u00b1\u20094.6; VAS: 6.8\u2009\u00b1\u20093.2 vs 6.1\u2009\u00b1\u20091.6). However, patients reported significantly greater satisfaction in two sensory domains and rated three domains as more important (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.05). No deterioration in any attribute was observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      The liquid VP3 nasal spray device delivering mometasone furoate demonstrated reliable\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      performance and favorable patient acceptability in UACS. The correspondence between deposition behavior and patient-reported tolerability supports its suitability for INCS delivery and warrants further evaluation in larger, longer-term studies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/19412711261420781","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:50:31Z","timestamp":1770220231000},"page":"213-220","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating\n                    <i>In Vitro<\/i>\n                    Performance and\n                    <i>In Vivo<\/i>\n                    Patient-Reported Outcomes of a Mometasone Furoate Nasal Spray Device: A Translational Evaluation"],"prefix":"10.1177","volume":"39","author":[{"given":"Alessandra","family":"Sorano","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Patterlini","sequence":"additional","affiliation":[{"name":"Department of Food and Drugs, University of Parma, Parma, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Sonvico","sequence":"additional","affiliation":[{"name":"Department of Food and Drugs, University of Parma, Parma, Italy."},{"name":"Biopharmanet-TEC, Research Center for the Innovation of Health Products, University of Parma, Parma, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fabietti","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Benuzzi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Vitale","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Lavorini","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Buttini","sequence":"additional","affiliation":[{"name":"Department of Food and Drugs, University of Parma, Parma, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.06.049"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01136-2019"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02278-w"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03171-y"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.05.017"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.s389875"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071353"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(03)02085-0"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16080989"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-009-0002-4"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2016.05.003"},{"key":"e_1_3_3_14_2","unstructured":"U.S. Food and Drug Administration. Nasal Spray and Inhalation Solution Suspension and Spray Drug Products\u2014Chemistry Manufacturing and Controls Guidance for Industry. Silver Spring (MD): FDA; 2023. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/nasal-spray-and-inhalation-solution-suspension-and-spray-drug-products"},{"key":"e_1_3_3_15_2","unstructured":"U.S. Food and Drug Administration. Nasal Spray and Inhalation Solution Suspension and Spray Drug Products: Chemistry Manufacturing and Controls Documentation. Guidance for Industry. Silver Spring (MD): Center for Drug Evaluation and Research (CDER) FDA; 2025. Available from: https:\/\/www.fda.gov\/media\/70877\/download"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114018"},{"issue":"1","key":"e_1_3_3_17_2","first-page":"140","article-title":"The importance of viscosity on nasal spray deposition and retention","volume":"9","author":"Djupesland PG","year":"2019","unstructured":"Djupesland PG, , Skretting A, , Winderen M, et al. The importance of viscosity on nasal spray deposition and retention. Drug Deliv Transl Res, 2019; 9(1):140\u2013148.","journal-title":"Drug Deliv Transl Res"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.02.026"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-011-0417-6"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2012.33.3560"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02725"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.07.021"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106248"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2013.34.3633"}],"container-title":["Journal of Aerosol Medicine and Pulmonary Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19412711261420781","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19412711261420781","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19412711261420781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T23:16:28Z","timestamp":1789254988000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19412711261420781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10,1]]}},"alternative-id":["10.1177\/19412711261420781"],"URL":"https:\/\/doi.org\/10.1177\/19412711261420781","relation":{},"ISSN":["1941-2711","1941-2703"],"issn-type":[{"value":"1941-2711","type":"print"},{"value":"1941-2703","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]}}}